SEARCH

SEARCH BY CITATION

References

  • Aupperlee MD, Haslam SZ, 2007: Differential hormonal regulation and function of progesterone receptor isoforms in normal adult mouse mammary gland. Endocrinology 148, 22902300.
  • Axlund SD, Sartorius CA, 2012: Progesterone regulation of stem and progenitor cells in normal and malignant breast. Mol Cell Endocrinol 357, 7179.
  • Ballare C, Uhrig M, Bechtold T, Sancho E, Di Domenico M, Migliaccio A, Auricchio F, Beato M, 2003: Two domains of the progesterone receptor interact with the estrogen receptor and are required for progesterone activation of the c-Src/Erk pathway in mammalian cells. Mol Cell Biol 23, 19942008.
  • Beijerink NJ, Bhatti SF, Okkens AC, Dieleman SJ, Duchateau L, Kooistra HS, 2008: Pulsatile plasma profiles of FSH and LH before and during medroxyprogesterone acetate treatment in the bitch. Theriogenology 70, 179185.
  • Bhatti SF, Rao NA, Okkens AC, Mol JA, Duchateau L, Ducatelle R, van den Ingh TS, Tshamala M, Van Ham LM, Coryn M, Rijnberk A, Kooistra HS, 2007: Role of progestin-induced mammary-derived growth hormone in the pathogenesis of cystic endometrial hyperplasia in the bitch. Domest Anim Endocrinol 33, 294312.
  • Brisken C, Duss S, 2007: Stem cells and the stem cell niche in the breast: an integrated hormonal and developmental perspective. Stem Cell Rev 3, 147156.
  • Daniel AR, Hagan CR, Lange CA, 2011: Progesterone receptor action: defining a role in breast cancer. Expert Rev Endocrinol Metab 6, 359369.
  • Gorlinger S, Kooistra HS, van den Broek A, Okkens AC, 2002: Treatment of fibroadenomatous hyperplasia in cats with aglepristone. J Vet Intern Med 16, 710713.
  • Gracanin A, van Wolferen ME, Sartorius CA, Brenkman AB, Schoonen WG, Mol JA, 2012: Loss of AF3 Domain Function in Canid Progesterone Receptor. Endocrinology, accepted.
  • Lantinga-van Leeuwen IS, van Garderen E, Rutteman GR, Mol JA, 2000: Cloning and cellular localization of the canine progesterone receptor: co-localization with growth hormone in the mammary gland. J Steroid Biochem Mol Biol 75, 219228.
  • Leslie KK, Stein MP, Kumar NS, Dai D, Stephens J, Wandinger-Ness A, Glueck DH, 2005: Progesterone receptor isoform identification and subcellular localization in endometrial cancer. Gynecol Oncol 96, 3241.
  • Millanta F, Calandrella M, Vannozzi I, Poli A, 2006: Steroid hormone receptors in normal, dysplastic and neoplastic feline mammary tissues and their prognostic significance. Vet Rec 158, 821824.
  • Mol JA, van Garderen E, Selman PJ, Wolfswinkel J, Rijnberk A, Rutteman GR, 1995: Growth hormone mRNA in mammary gland tumors of dogs and cats. J Clin Invest 95, 20282034.
  • Mulac-Jericevic B, Lydon JP, DeMayo FJ, Conneely OM, 2003: Defective mammary gland morphogenesis in mice lacking the progesterone receptor B isoform. Proc Nat Acad Sci USA 100, 97449749.
  • Pfaffl MW, Horgan GW, Dempfle L, 2002: Relative expression software tool (REST) for group-wise comparison and statistical analysis of relative expression results in real-time PCR. Nucleic Acids Res 30, e36.
  • Rao NA, van Wolferen ME, Gracanin A, Bhatti SF, Krol M, Holstege FC, Mol JA, 2009: Gene expression profiles of progestin-induced canine mammary hyperplasia and spontaneous mammary tumors. J Physiol Pharmacol 60(Suppl. 1), 7384.
  • Scarpin KM, Graham JD, Mote PA, Clarke CL, 2009: Progesterone action in human tissues: regulation by progesterone receptor (PR) isoform expression, nuclear positioning and coregulator expression. Nucl Recept Signal 7, e009.
  • Selman PJ, Mol JA, Rutteman GR, van Garderen E, Rijnberk A, 1994: Progestin-induced growth hormone excess in the dog originates in the mammary gland. Endocrinology 134, 287292.
  • Tan H, Yi L, Rote NS, Hurd WW, Mesiano S, 2012: Progesterone receptor-A and -B have opposite effects on proinflammatory gene expression in human myometrial cells: implications for progesterone actions in human pregnancy and parturition. J Clin Endocrinol Metab 97, E719E730.
  • Thackray VG, Hunnicutt J, Memon AK, Ghochani Y, Mellon PL, 2009: Progesterone inhibits basal and gonadotropin-releasing hormone induction of luteinizing hormone beta-subunit gene expression. Endocrinology 150, 23952403.
  • Tung L, Shen T, Abel MG, Powell RL, Takimoto GS, Sartorius CA, Horwitz KB, 2001: Mapping the unique activation function 3 in the progesterone B-receptor upstream segment. Two LXXLL motifs and a tryptophan residue are required for activity. J Biol Chem 276, 3984339851.